Alzheimer’s clinical trials
The clinical trials unit at Caulfield Hospital specialises in new treatments for Alzheimer’s disease.
Our Alzheimer's trials
Our team consists of doctors, nurses, neuropsychologists, and clinical trials coordinators with expertise in clinical trials for people with cognitive problems, including various types of dementia and neurodegenerative disorders.
Our main focus is on new medications for Alzheimer’s disease, both disease modifying drugs and symptomatic therapies. There are many treatments under development and we are usually recruiting interested patients into new studies.
Accessing Alzheimer's clinical trials
In order to be eligible to enter a clinical trial, participants need to have a formal diagnosis of Alzheimer’s disease or mild cognitive impairment due to Alzheimer’s. The diagnosis is usually made by a specialist, often a geriatrician, psychogeriatrician, neurologist or psychiatrist. Our service does not provide diagnostic cognitive assessments.
If you would like to know more about current clinical trials please send us a recent copy of:
- A health summary from the GP, which generally includes current medications and a list of past and current medical conditions,
- Any specialist letters relating to the diagnosis,
- The results of a MRI or CT brain scan that was undertaken for diagnosis,
- A current Mini Mental State Examination (MMSE) score if available. Your doctor will know what this is.
Please e-mail this information to email@example.com.